0001575872-22-000435.txt : 20220517 0001575872-22-000435.hdr.sgml : 20220517 20220517164825 ACCESSION NUMBER: 0001575872-22-000435 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220517 DATE AS OF CHANGE: 20220517 GROUP MEMBERS: ZUHLKE VENTURES AG SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Tenon Medical, Inc. CENTRAL INDEX KEY: 0001560293 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 455574718 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-93668 FILM NUMBER: 22935277 BUSINESS ADDRESS: STREET 1: 104 COOPER CT. CITY: LOS GATOS STATE: CA ZIP: 95032 BUSINESS PHONE: (408) 649-5760 MAIL ADDRESS: STREET 1: 104 COOPER CT. CITY: LOS GATOS STATE: CA ZIP: 95032 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Zuhlke Ventures AG CENTRAL INDEX KEY: 0001923427 IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ZURCHERSTRASSE 39J CITY: SCHLIEREN STATE: V8 ZIP: 8952 BUSINESS PHONE: 41 43 216 6611 MAIL ADDRESS: STREET 1: ZURCHERSTRASSE 39J CITY: SCHLIEREN STATE: V8 ZIP: 8952 SC 13G 1 cm067_sc13g.htm SCHEDULE 13G

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

SCHEDULE 13G

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

 

Tenon Medical, Inc.

(Name of Issuer)

 

Common Stock, par value $0.001 per share

(Title of Class of Securities)

 

88066N105

(CUSIP Number)

 

April 29, 2022

(Date of Event Which Requires Filing of this Statement)

 

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨Rule 13d-1(b)
xRule 13d-1(c)
¨Rule 13d-1(d) 

 

 

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 1 

 

 

CUSIP No. 88066N105 Schedule 13G

 

  1.    

  Name of Reporting Persons

 

 Zuhlke Ventures AG

  2.    

  Check the Appropriate Box if a Member of a Group (see instructions)

 

  (a) ¨      (b) ¨

  3.    

  SEC USE ONLY

 

  4.    

   Citizenship or Place of Organization

 

  Switzerland

 

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With:

     5.    

  Sole Voting Power

2,447,728

  6.    

  Shared Voting Power

 0

  7.    

  Sole Dispositive Power

2,447,728

  8.    

  Shared Dispositive Power

0

 

9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

2,447,728

 

10.    

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

 ¨

11.    

  Percent of Class Represented by Amount in Row 9

 21.8%

12.    

  Type of Reporting Person (see instructions)

 Company

  

 

 2 

 

 

Item 1.

 

(a) Name of Issuer: The name of the issuer is Tenon Medical, Inc. (the “Issuer”).

 

(b) Address of Issuer’s Principal Executive Offices: 104 Cooper Court, Los Gatos, CA 95032.

 

Item 2.

 

(a) Name of Person Filing: The name of the person filing is:

 

(i) Zuhlke Ventures AG (“Zuhlke”).

 

(b) Address of Principal Business Office, or if None, Residence:

 

(i) The principal executive office of Zuhlke is Zurcherstrasse 39j, Schlieren, Switzerland 8952.

 

(c) Citizenship: Switzerland.

 

(d) Title of Class of Securities: The title of the class of securities is Common Stock, par value $0.001 per share.

 

(e) CUSIP Number: The CUSIP number for the Common Stock is 88066N105.

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 

(b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 

(c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 

(d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

 

(e) ¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

(f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

(g) ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

 

(h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

(i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

(j) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

Item 4. Ownership

 

(a) Amount beneficially owned:

 

(i) Zuhlke owns 2,447,728 shares of Common Stock.

 

(b) Percent of class:

 

(i) 21.8%

 

(c) Number of shares as to which the person has:

 

(i) Sole power to vote or to direct the vote: 2,447,728.

 

(ii) Shared power to vote or to direct the vote: 0.

 

(iii) Sole power to dispose or to direct the disposition: 2,447,728.

 

(iv) Shared power to dispose or to direct the disposition: 0.

 

Item 5. Ownership of 5 Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ].

 

Item 6. Ownership of More than 5 Percent on Behalf of Another Person.

 

Other than as set forth herein, no other person has the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, the securities reported herein.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

 

Not applicable.

 

Item 8. Identification and Classification of Members of the Group

 

Not applicable.

 

Item 9. Notice of Dissolution of Group

 

Not applicable.

 

Item 10. Certifications

 

Not applicable.

 

 3 

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: May 17, 2022

 

  ZUHLKE VENTURES AG
   
  By: /s/ Elena Jasvoin
    Elena Jasvoin
    Chief Financial Officer of Zuhlke Ventures AG

 

 4